Exenatide is eliminated primarily through the kidneys, and its use is not recommended in patients with a creatinine clearance (CrCl) of 30 mL/min
BPC-157 repairs locally while TB-500 heals systemically

Seek immediate medical attention if you experience: Severe dizziness accompanied by chest pain, shortness of breath, or palpitations Dizziness with loss of consciousness or near-fainting episodes Dizziness associated with severe headache, visual changes, or neurological symptoms such as weakness, numbness, or difficulty speaking Signs of severe dehydration, including decreased urination, extreme thirst, confusion, or rapid heartbeat Symptoms suggestive of hypoglycemia that do not resolve with carbohydrate intake Severe abdominal pain with or without vomiting (possible pancreatitis) Signs of allergic reaction such as rash, itching, swelling of face/throat, or difficulty breathing Prolonged vomiting or diarrhea lasting more than 24 hours (risk of dehydration and kidney injury) Contact your healthcare provider within 24-48 hours if: Dizziness persists for more than a few days despite hydration and positional precautions You experience frequent episodes of lightheadedness that interfere with daily activities Dizziness worsens after a dose increase You have documented orthostatic hypotension (significant blood pressure drop upon standing) Dizziness is accompanied by persistent nausea, vomiting, or diarrhea Your healthcare provider may recommend laboratory testing to evaluate electrolytes, kidney function, and glucose levels

Dexmedetomidine alleviated sepsisinduced myocardial ferroptosis and septic heart injury
Lyttle MH, Docker MD, Hui HC, Caldwell CG, Aaron DT, Engqvist-Goldstein A, Flatgaard JE and Bauer KE
If GPX4 expression is reduced, EBV reactivation can result